If the defendant does not pay the above fine, 50,000 won.

The defendant, who operates a herb wholesaler, is not a pharmacy founder.

Any person who intends to engage in the business of manufacturing drugs shall obtain permission from the Commissioner of the Korea Food and Drug Administration, and when he/she intends to sell manufactured drugs by item, he/she shall obtain permission from the Commissioner of the Korea Food and Drug Administration for manufacture and sale items, no one shall sell manufactured drugs, store or display them for sale in violation of such permission, and no one, other than

The Defendant, without obtaining permission from the Commissioner of the Korea Food and Drug Administration for manufacturing and marketing marketing and marketing marketing approval, manufactured “natural saccination” by mixing 10 and 10 and female herb drugs, manufactured 40 kilograms of powder sacciny by using yellow dust and white half around March 2012, and sold the above natural natural saccination and sacciny to C.

Summary of Evidence

1. Partial statement of the defendant;

1. C’s legal statement;

1. Statement made by C of a witness in the fourth trial record;

1. Copy of the statement made to D by the police;

1. Documents printed out of import declaration form which is a metrographer, and output of the test report of health foods;

1. Application of Acts and subordinate statutes to the internal investigation report (the comparison of the nature of the foreign exchange of the peltos and the products of natural harmful exchange with the peltossa, the connection between natural toxins and peltosa, the toxic information of nicotine, the ingredients and surface materials of the father, the father, the prescription product license certificate of peltosin containing sulfur, the prescription product license of peltosin products purchased from the peltosa and copies of the results of natural toxicization products);

1. Relevant legal provisions concerning criminal facts, Articles 93(1)4, 31(1)4, 93(1)4, 31(2) of the Pharmaceutical Affairs Act, Article 93(1)4, Article 31(2) of the Pharmaceutical Affairs Act, Article 93(1)7, and Article 44(1) of the Pharmaceutical Affairs Act (the sales of drugs by a person who is not a pharmacy founder), and Article 93 of the Pharmaceutical Affairs Act.